Technology platform
Translatable AAV by Rational Design (TARD)
Based on the rational design AAV development strategy, overcome the challenge of vector development from animals to humans, and develop efficient tissue-targeted vectors
Gene editing
Develop in vivo gene editing tools and delivery systems with intellectual property rights
Production Process
Develop a high-efficiency and low-cost process production system, so that gene therapy is no longer expensive
Product pipeline
Based on gene replacement and gene editing, develop gene therapy drugs in the fields of ophthalmology, metabolism and nervous system.
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; font: 10.5px 'Trebuchet MS'; color: #000000; -webkit-text-stroke: #000000}
p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; font: 10.5px 'Songti SC'; color: #000000; -webkit-text-stroke: #000000}
span.s1 {font: 10.5px 'Songti SC'; font-kerning: none}
span.s2 {font-kerning: none}
span.s3 {font: 10.5px 'Trebuchet MS'; font-kerning: none}
上一页
1
下一页
copyright © 2021 INNOVEC 京ICP备2021023611号
E-mail:innovecbio@innovecbio.com